ABA is a biotech company, started to operate in 2013, with a vision to provide novel solution up-to-date problems. The company prioritized the R&D activities with its extensive experience on animal and human disease diagnostics and the technologies involved. In this direction, it aims to develop customized solutions to emerging issues, commercialize products to relevant markets, expand co-creation activities and product portfolio, and transfer technologies. Within its founding vision and mission, the company always considers all viability options from idea to the market.
ABA Biotech, in its earliest years, focused on the manufacturing of ELISA immunodiagnostics, the production of monoclonal and polyclonal antibodies, the production of recombinant proteins and recombinant protein based vaccines and drugs, and relatedly, the purification of antibodies and strapping/conjugating of enzymes. In time, ABA Biotech has designed and developed diverse panels of antigen and antibody based tests, and RT-qPCR and LAMP based nucleic acid detection kits for in vitro diagnostics of humans and animals. With this, ABA Biotech aimed to offer more customized solutions to the home and global markets, rather than simply trading products. Besides, to share and transfer technology, ABA Biotech has cooperated and still cooperates with various biotech companies specialized in the molecular diagnostics, next generation sequencing (NGS), genome editing, and bioinformatics solutions.
In the near future, the company plans to start vaccine production under the ABAvac Biotechnology Company. The investments on the design and construction, vaccine manufacturing and distribution, operation and management, and consultant services and training have been meticulously planned and necessary actions have been already undertaken. When it is fully operated, ABAvac will be the only company in Turkey and the Middle East – North Africa (MENA) attempted to establish a European standard (GMP certified) FMD and mRNA-based vaccine production. ABAvac team will harbor a group of scientists, researchers and developers with accumulative experiences in the relevant fields. Some members of ABAvac team had also established and managed three former FMD factories over the past 40 years. ABAvac has practical know-how to produce veterinary viral, bacterial, and parasitic vaccines, and dedication to improve veterinary livestock protection including: planning, developing, executing, producing and managing, guaranteeing the highest quality standards.
With its experienced staff and accumulative knowledge, the company aims to become a regional and global leader in the development and production of human and animal serological/molecular diagnostics and vaccine manufacturing.